Articles from Alpha Genesis, Inc.

SBIR, STTR, and other federal funding applicants can request study plans, written estimates, and letters of interest. AGI Ventures will separately consider selected biotechnology programs for follow-on research support and investment.

New venture-development division pairs strategic investment with the scientific expertise and preclinical research infrastructure of Alpha Genesis

New capability lets sponsors run programs from early rodent proof-of-concept through advanced nonhuman-primate translational studies with a single AAALAC-accredited, USDA-licensed partner.